7DEM

Crystal structure of P.aeruginosa LpxC in complex with inhibitor

7DEM の概要

• エントリーDOI: 10.2210/pdb7dem/pdb
• 分子名称: UDP-3-O-acyl-N-acetylglucosamine deacetylase, ZINC ION, 5-[4-[3-[[2-[(1~{S})-1-oxidanylethyl]imidazol-1-yl]methyl]-1,2-oxazol-5-yl]phenyl]pent-4-yn-1-ol, ... (4 entities in total)
• 機能のキーワード: udp-3-o-acyl-n-acetylglucosamine deacetylase enva, lpxc, pseudomonas aeruginosa, hydrolase
• 由来する生物種: Pseudomonas aeruginosa PAO1
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 33563.42

構造登録者

Mima, M.,Ushiyama, F.,Matsuda, Y. (登録日: 2020-11-04, 公開日: 2021-01-13, 最終更新日: 2023-11-29)

主引用文献

Ushiyama, F.,Takashima, H.,Matsuda, Y.,Ogata, Y.,Sasamoto, N.,Kurimoto-Tsuruta, R.,Ueki, K.,Tanaka-Yamamoto, N.,Endo, M.,Mima, M.,Fujita, K.,Takata, I.,Tsuji, S.,Yamashita, H.,Okumura, H.,Otake, K.,Sugiyama, H.
Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: Discovery of TP0586532.
Bioorg.Med.Chem., 30:115964-115964, 2020

PubMed Abstract: Infectious diseases caused by resistant Gram-negative bacteria have become a serious problem, and the development of therapeutic drugs with a novel mechanism of action and that do not exhibit cross-resistance with existing drugs has been earnestly desired. UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) is a drug target that has been studied for a long time. However, no LpxC inhibitors are available on the market at present. In this study, we sought to create a new antibacterial agent without a hydroxamate moiety, which is a common component of the major LpxC inhibitors that have been reported to date and that may cause toxicity. As a result, a development candidate, TP0586532, was created that is effective against carbapenem-resistant Klebsiella pneumoniae and does not pose a cardiovascular risk.

PubMed: 33385955
DOI: 10.1016/j.bmc.2020.115964

実験手法

X-RAY DIFFRACTION (1.9 Å)